were used. Optical rotations were recorded on a Perkin-Elmer 243B digital polarimeter. NMR spectra were recorded on Inova 500 MHz NMR spectrometers. HR-ESI-MS spectra were measured on a Bruker APEX IV FTMS mass spectrometer in positive-ion mode. GC were measured on an Agilent 6890N instrument [HP-5 capillary column (28 m  0.32 mm i.d.); detection, FID; detector temperature, 260 C; column temperature, 180 C; carrier gas, N 2 ; flow rate, 40 mL/min)]. All solvents used were of analytical grade (Beijing Chemical and Industry Factory). Silica gel (200300 mesh; Qingdao Mar. Chem. Ind. Co. Ltd.), Sephadex LH-20 gel (Pharmacia), and C 18 reversed-phase silica gel (150200 mesh, Merck, performed by applying an N 2 pressure of 0.12 Mpa) were used for column chromatography. 
Extraction and isolation
The n-BuOH extract (120 g) was subjected to silica gel column chromatography (CC) and eluted with a gradient of CHCl 3 MeOH (10:12:1) to afford nine fractions (Frs. IIX).
Fr. IV (25 g) was subjected to silica gel CC (4.0  60 cm; 400 g) and eluted with PEacetone Fr. VI (10 g) was subjected to silica gel CC (4.0  60 cm; 400 g) and eluted with CHCl 3 MeOH (4:1; 2000 mL) to obtain two portions (A and B). Portion B was further subjected to silica gel CC (4.0  60 cm; 400 g) with elution of PEacetone (1:3; 1000 mL), followed by semi-preparative HPLC (25% MeOHH 2 O) separation to afford 1 (13 mg, Rt = 23.7 min) and 6 (203 mg, Rt = 17.8 min).
Fr. VII (10 g) was isolated by silica gel CC (4.0  60 cm; 300 g) eluted with a gradient of EtOAcMeOH (15:1, 10:1 and 7.5:1, each 1500 mL) to get Frs. VII 1 VII 6 . A portion of Fr. 
Acid hydrolysis and sugar analysis
Each compound (13, 2 mg each) was heated in 5 mL of 10% HCldioxane (1:1) at 80 C for 4 h. After removing the dioxane, the solution was extracted with EtOAc (3 mL × 3). The aqueous layer was neutralized with NaHCO 3 and evaporated until dryness. A small amount of solid residue was dissolved in MeOH and analyzed by TLC (CHCl 3 MeOHH 2 O 8:5:1). The spots were visualized by spraying 95% EtOHH 2 SO 4 anisaldehyde [9:0.5:0.5 (v:v)], followed by heating at 120 C for 10 min. Glucose (R f = 0.30) was detected in compounds 13. TLC results were confirmed by GC analyses. The solid residue from the aqueous layer was dissolved in anhydrous pyridine (100 mL). L-cysteine methyl ester hydrochloride (0.1 M, 200 mL) was added, and the mixture was warmed at 60 C for 1 h. The trimethylsilylation reagent hexamethyldisilazane (HMDS)/chlorotrimethylsilane/pyridine 2:1:10 (Acros Organics) was added, and the mixture was warmed at 60 C for 30 min. The thiazolidine derivative was analyzed by GC for sugar identification: D-glucose derivative (t R = 12.45 min).
Bioactivity assay
Cell culture and treatment: Rat pheochromocytoma line, undifferentiated PC12 cells were routinely maintained in F12 Kaighn's medium supplemented with 10% horse serum, 2.5% fetal bovine serum, and streptomycin (100 g/mL)penicillin (100 IU/mL) at 37 C under an atmosphere of 95% air and 5% CO 2 . After the cells attached (24 h) to the plates, they were pretreated with each compound for 1 h and then incubated with 150 M/L H 2 O 2 for 24 h.
After each treatment, the MTT assay was performed in order to evaluate cell viability. The treated cells were incubated with 0.5 mg/mL MTT at 37 C for 4 h in the dark, and 200 L DMSO was added to the culture medium and mixed with a pipette until the blue formazan dissolved completely. The optical density of formazan was measured at 570 nm using a microplated reader. (Sunrise; Tecan). The control consisted of the medium plus DMSO or water with no added compound; its absorbance was set at 100%. 
Fig. 12S
13 C-NMR spectrum of compound 3 (DMSO-d 6 , 125 MHz).
